You can buy GHK-Cu as a cosmetic cream over the counter, as research-supply powder online, or as a compounded injectable on a prescription. All three channels are real. Where to buy GHK-Cu is really a question about which of the three you want, because they carry very different evidence behind them.
GHK-Cu
Referenced in this guideThe GHK-Cu referenced throughout this article, supplied as a research compound with a certificate of analysis matched to the lot you receive — the check this site argues you should hold any supplier to.
GHK-Cu is the copper-bound form of the tripeptide glycyl-L-histidyl-L-lysine, available as a cosmetic cream, research powder, or a compounded injection. The certificate should document CAS 49557-75-7, molecular weight 340.4 g/mol and copper at ~17% by mass. Expect $40-$80 per 50 mg vial or $40-$80 per 30 mL cream. Topical carries decades of research; injectable carries none.
Quick answer
Third-party tested GHK-Cu runs $40–$140 per vial. The powder should be freeze-dried and visibly blue. A credible CoA from an ISO 17025-accredited lab, the international testing-quality standard, shows HPLC purity above 98%, correct mass-spec identity, and atomic copper content measured by ICP-MS.
The blue color is your first identity check, and it costs nothing. A white or off-white powder is not the molecule characterized in the published research.
Where can you buy GHK-Cu?
GHK-Cu reaches buyers through three real channels: cosmetic finished products sold over the counter, research-supply powder sold online, and injectable preparations from a compounding pharmacy on a prescription. Each has different rules, formats and gaps.
- Cosmetic topical, over the counter: $40–$80 per 30 mL jar. The format the published dermatology research actually used. No prescription, no concentration disclosed.
- Research supply, online: $0.70–$1.60 per mg as blue lyophilized powder. Best documentation, no formulation, laboratory-use labeling.
- Compounding pharmacy, injectable: Needs a prescriber. GHK-Cu is one of the few peptides here this route is genuinely open for. It also has the weakest evidence behind it.
The second channel is the one where the vendor is your only quality control, so here are six, all checked on 13 August 2026 against what each will show you before you pay: a third-party certificate you can open, and whether the testing lab is named in the vendor's own copy or only inside the PDF. We did not verify GHK-Cu prices, so there is no price column here — pricing across these same vendors is benchmarked on BPC-157 in our full vendor comparison, where the spread runs $6.30–$12.45 per mg. Stock varies by compound, so check each catalogue for GHK-Cu.
| Vendor | COA | Lab named | Ships free at |
|---|---|---|---|
| Peptriva Premium brand | Third-party, published | Product page (Freedom Diagnostics) | $200 |
| Sports Technology Labs | Third-party, published | Site and document (MZ Biolabs, Colmaric) | $149 |
| Swiss Chems | Third-party, published | Site FAQ (Janoshik) | $100 |
| Core Peptides | Third-party, published (A2LA #6377.01.01) | Document only (Vanguard Laboratory) | $200 |
| PS Peptides | Third-party, published | Document only (North American Diagnostics) | $200 |
| Red Rock Peptides | Claimed, none published | Not named | Not offered |
Three caveats travel with that table. Peptriva and Red Rock sell 10 mg vials only, so their per-milligram figures in the BPC-157 benchmark are not comparable with a 5 mg row. Swiss Chems sells its BPC-157 as the arginine salt rather than the plain peptide, so it is not a like-for-like product. And Red Rock publishes no certificate of analysis at all, despite advertising verified COAs. Where To Buy Peptides earns a commission on purchases made through its links, Peptriva included — see our disclosure.
The identity check specific to GHK-Cu: CAS 49557-75-7, a mass of 340.4 g/mol for the tripeptide, and atomic copper at roughly 17% by mass — without that last figure nothing on the report separates the copper complex from bare GHK.
1. Cosmetic-grade finished topical
Cosmetic finished GHK-Cu products are creams, serums and gels regulated by the FDA as cosmetics rather than drugs. The active ingredient reads "copper tripeptide-1" or "tripeptide-1 copper" on the box. This is the format the published dermatology research actually used, and it runs $40–$80 per 30 mL jar.
What this channel doesn't give you is a known peptide concentration. Most cosmetic products list GHK-Cu in the ingredients without specifying mg per mL. The actual dose is formulator-controlled and not on the label.
2. Research-supply (laboratory use only)
Research-supply GHK-Cu is blue freeze-dried powder in vials, labeled for research use only. Per-mg pricing runs $0.70–$1.60, and CoA quality should be highest in this channel. Standard vial sizes are 50 mg, 100 mg and 200 mg.
What this channel doesn't give you is a finished formulation. The powder needs reconstitution, plus a suitable carrier for any topical-application research. The label restricts use to laboratory work.
3. Compounding pharmacy (injectable)
Compounding pharmacies operating under 503A rules can prepare injectable GHK-Cu. Those rules are the part of US drug-compounding law that lets a pharmacy make custom preparations against a prescription. A doctor writes it, the pharmacy mixes and ships.
What this channel doesn't give you is evidence. Injectable GHK-Cu has zero controlled human trials as of 2026. The 2026 Sports Medicine review grouped it with grey-market peptides lacking rigorous safety data.
Where this falls short
The GHK-Cu topical evidence base is real but old. Many studies date from the 1980s and 1990s, with sample sizes in the low double digits. The injectable evidence is essentially zero.
Vendors selling injectable GHK-Cu for "systemic senescence" or "IBD treatment" are crossing the evidence line. The 2026 Sports Medicine review flagged the injectable form as outside supported use. If you want the validated version, topical is where the science was done.
What is GHK-Cu, exactly?
GHK-Cu, often labeled "copper tripeptide-1" in cosmetics, is the copper-bound form of glycyl-L-histidyl-L-lysine. Loren Pickart discovered the peptide in 1973, isolating it from human plasma while screening fractions that restored healthy growth in aged rat liver cells. He published it in Nature and has spent 50 years characterizing it.
GHK-Cu is endogenous, meaning your own body makes it. A 2020 review by Dou and colleagues reports circulating levels averaging 200 ng/mL at age 20, dropping to 80 ng/mL by age 60. That decline is among the reasons it became a longevity research target.
The biochemistry that sets GHK-Cu apart is the copper. Two parts of the peptide form a binding pocket around a copper ion, and the resulting complex absorbs red light and transmits blue. That's why properly complexed material is deep blue, as Pickart and Margolina describe. Your identity check is unusually simple here. It should be blue.
Properly complexed GHK-Cu is deep blue. A pale or white powder labeled "GHK-Cu" is either uncomplexed peptide or only partially complexed. Either way, it isn't the molecule in the published literature.
The simplest identity check in research peptides
What should you check before buying GHK-Cu?
Check GHK-Cu for four things. The powder must be blue rather than white. The CoA must report atomic copper near 17%. The form must match the evidence you're relying on, and the per-mg price should sit in the $0.65–$1.60 band. The general eight peptide-buyer criteria apply on top.
1. The powder must be blue, not white.
The most common mix-up in the GHK-Cu market is between the copper-bound form, which is deep blue, and the bare peptide, which is white or off-white. The published research on collagen synthesis, blood-vessel formation and inflammation was all done with the copper-bound form.
A white powder labeled "GHK-Cu" is either uncomplexed peptide or only partly complexed. Either way, it isn't the molecule in the published literature. The visible color is a free identity check.
2. The CoA must show atomic copper content.
A credible GHK-Cu CoA reports copper percentage measured by ICP-MS or AAS, two lab techniques that quantify metals in a sample. The theoretical copper content for fully complexed GHK-Cu is 17% by mass. That's one 63.5 g/mol copper atom per 340 g/mol peptide molecule.
If the CoA reports HPLC purity for the peptide but skips copper content, there is a peptide-purity number but no confirmation of the "-Cu" part of the name.
3. Match the form to the evidence.
The cosmetic-dermatology evidence base is for topical GHK-Cu. Clinical trials in photoaged skin and chronic wounds, modern hydrogel delivery work, and 2025 liposomal-encapsulation research. The injectable form common in the research-peptide community has essentially zero controlled human trials as of 2026.
The 2026 Sports Medicine review grouped injectable GHK-Cu with grey-market peptides lacking rigorous human safety data. See our injectable vs topical comparison for the full breakdown.
Topical cosmetic-grade material is matched to the topical evidence base. Lyophilized blue vial powder is appropriate for research chemistry requiring a characterized reference compound.
4. Bigger vials, lower per-mg cost.
GHK-Cu ships in 50 mg, 100 mg, or 200 mg vials, about 10x larger than the 5-10 mg standard for most peptides. Two reasons. The synthesis is cheap: three amino acids, no modifications, plus a copper-binding step. And GHK-Cu is unusually stable at room temperature as a freeze-dried solid.
The cosmetic industry works with GHK-Cu because finished topical products can sit on a shelf for months. Reconstituted solution should still be refrigerated and expiration dates observed, but storage is more forgiving than for GLP-1-class peptides.
Regenerative and protective actions of the GHK-Cu peptide in the light of the new gene data.
Pickart & Margolina, reviewed in IJMS, 2018
What does GHK-Cu cost in 2026?
GHK-Cu costs $40–$80 for a 50 mg vial and $40–$80 for a 30 mL finished cream. Per mg it's the cheapest peptide in most research catalogs: three amino acids, well-established synthesis, room-temperature-stable powder, and vials 10x larger than typical. Third-party tested retail in 2026:
- 50 mg vial: $40-$80, or $0.80-$1.60 per mg. The standard third-party tested size.
- 100 mg vial: $70-$140, or $0.70-$1.40 per mg. The size most cosmetic researchers buy.
- 200 mg vial: $130-$260, or $0.65-$1.30 per mg. Bulk research use, best per-mg.
- Finished topical (cream, serum): $40-$80 per 30 mL jar. Pre-formulated and ready to apply.
Below $30 for a 50 mg vial deserves a question. That's under typical bulk synthesis cost, and it usually means uncomplexed GHK or low copper content. Above $80 is retail markup.
For finished topical products, the price reflects the formulation work as much as the GHK-Cu. The carrier system, whether liposomes, hyaluronic acid or tallow, is doing real bioavailability work.
Is GHK-Cu legal to buy?
Yes. We count two open over-the-counter channels for GHK-Cu, plus the prescription route for compounded injectable.
As a topical cosmetic ingredient under FDA cosmetic regulations, labeled "tripeptide-1" or "copper tripeptide-1", GHK-Cu has been used since the 1980s. As a research reference compound, it sells under the same Research Use Only framework as other research peptides.
Neither the FDA nor the EMA has approved GHK-Cu as a therapeutic drug. It's regulated as a cosmetic, not a medicine. The FDA's 2023 categorization that flagged BPC-157 didn't include GHK-Cu. WADA hasn't placed GHK-Cu on the Prohibited List.
Those are the two legitimate channels: cosmetic-grade topical products and third-party tested reference compound. The two channels differ in manufacturing standards and intended use.
What are the red flags when buying GHK-Cu?
The GHK-Cu red flag we weigh heaviest is a powder that isn't blue, because the color is the free identity check. Seven warning signs we'd skip:
- White, off-white, or pale tan powder. Properly complexed GHK-Cu is deep blue. A pale powder is uncomplexed or only partially complexed. Not the molecule in the published literature.
- CoA without atomic copper content. HPLC peptide purity is necessary but not sufficient. Without ICP-MS or AAS copper data, there is no verification of the "-Cu" part of the molecule.
- Confusion between "GHK" and "GHK-Cu." Some suppliers list both as the same product. They aren't. The bioactive form in the literature is the copper-complexed version.
- Clinical claims for injectable use. "Reverses systemic aging." "Treats IBD." The injectable evidence base in humans is zero controlled trials. These claims attract FDA enforcement.
- Cosmetic vs third-party tested mislabeling. The two are made under different standards. Research-chemical powder isn't appropriate for direct skin application without formulation. Cosmetic-grade finished products aren't reference standards.
- Pricing below $30 per 50 mg vial. Likely uncomplexed GHK or low copper content.
- Vendor's in-house QC instead of third-party testing. Independent ISO 17025 verification of HPLC purity, mass-spec identity, and copper content is the standard.
Copper Peptide Tallow Cream
The finished topical form. GHK-Cu pre-formulated in a tallow carrier that addresses the historical permeation challenge described in the 2025 Ogórek skin-permeation paper. The form matched to the topical evidence base the cosmetic-dermatology literature is built on. 30 mL jar, ready-to-apply.
Frequently asked questions.
Is GHK-Cu legal to buy?
Yes, in two channels. As a cosmetic ingredient or finished topical under FDA cosmetic regulations, and as a research reference compound. GHK-Cu isn't on the WADA Prohibited List. The FDA didn't include it in the 2023 categorization that affected BPC-157. Selling for human injectable consumption isn't permitted. Buying as a topical or research compound is.
How much does GHK-Cu cost?
third-party tested lyophilized GHK-Cu in 2026: $40-$80 per 50 mg vial, $70-$140 per 100 mg vial, $130-$260 per 200 mg vial. Finished topical cosmetics: $40-$80 per 30 mL jar. Per-mg pricing is among the lowest of any peptide because the synthesis is short and well-established and the vials are larger than typical.
What should a GHK-Cu CoA show?
Three things matter on a GHK-Cu CoA. HPLC purity above 98% with the chromatogram. Mass-spec at 340.4 g/mol for the bare peptide. And atomic copper content by ICP-MS or AAS, about 17% by mass for properly complexed material.
The copper measurement is what verifies the "-Cu" part. Without it, you have a peptide-purity number and no copper confirmation. The lab should be ISO 17025-accredited and named on the report.
Why is GHK-Cu blue?
The blue color comes from copper sitting in a specific geometry inside the peptide's binding pocket. Copper coordinated this way absorbs red light and transmits blue. The color is a visible signature of proper copper complexation. White or off-white powder labeled "GHK-Cu" is uncomplexed or partially complexed. Not the molecule in the published literature.
Topical vs injectable: which has better evidence?
Topical GHK-Cu wins by a long way. Five decades of cosmetic-dermatology research, small controlled trials in photoaged skin and chronic wounds, and reproducible in-vitro biology including about 49% elastase inhibition. Modern delivery research uses liposomal and hyaluronic acid carriers.
Injectable GHK-Cu in humans has effectively zero controlled trials as of 2026. The preclinical rodent work in colitis, silicosis and wound-healing models is real but rodent-bound. The 2026 Sports Medicine review grouped it with grey-market peptides lacking rigorous human safety data.
How does GHK-Cu compare to Argireline or Matrixyl?
All three are short-peptide cosmetic ingredients with different mechanisms. GHK-Cu has been investigated for fibroblast stimulation, collagen synthesis, elastase inhibition and angiogenesis.
Argireline, or acetyl hexapeptide-8, is marketed for botulinum-like effects on expression lines, though the human evidence is thinner than the marketing. Matrixyl is a procollagen fragment designed to signal collagen synthesis. GHK-Cu has the deepest published evidence base of the three by a substantial margin.
What's the difference between GHK and GHK-Cu?
GHK is the bare tripeptide. Three amino acids, molecular weight 340.4 g/mol. GHK-Cu is the copper-bound version. The published activity was characterized with the copper-bound form. The color is the immediate tell: GHK is white. GHK-Cu is deep blue. For research matching the published literature, GHK-Cu is the molecule of interest.
What to know now
- The blue color is a free identity check. Properly complexed GHK-Cu is deep blue. White or off-white is uncomplexed.
- Copper content on the CoA matters. About 17% by mass, measured by ICP-MS or AAS. Without it, no copper confirmation.
- Pricing: $40-$140 per vial depending on size. Three amino acids and well-established synthesis make it one of the cheapest peptides per mg.
- Topical evidence is well-supported. Five decades of research, small controlled trials, modern hydrogel delivery work.
- Injectable evidence is preclinical-only. Zero controlled human trials. The 2026 Sports Medicine review applies.
- Match the form to the evidence. Topical cosmetic-grade for skin or wound use. third-party tested lyophilized powder for lab research. They aren't interchangeable.
What we're watching
The big GHK-Cu development we're tracking is whether any controlled human trial of the injectable form publishes. Randomized, blinded, real endpoints. The preclinical rodent literature in colitis, silicosis and wound-healing models gives mechanistic hooks for several uses.
But until those translate into controlled human investigation, the topical-versus-injectable asymmetry stays exactly where it is. We wouldn't expect that to shift soon.
We're also watching the modern delivery research: liposomal encapsulation, hyaluronic acid hydrogels, photo-crosslinkable nanofibers. That work is solving the historical poor-permeation problem for topical GHK-Cu, and we think it's the most credible direction for the next decade.
References
- Pickart, L., & Margolina, A. (2018). Regenerative and protective actions of the GHK-Cu peptide in the light of the new gene data. International Journal of Molecular Sciences, 19(7), 1987. https://doi.org/10.3390/ijms19071987
- Dou, Y., Lee, A., Zhu, L., Morton, J., & Ladiges, W. (2020). The potential of GHK as an anti-aging peptide. Aging Pathobiology & Therapeutics, 2(1), 58–61. https://doi.org/10.31491/apt.2020.03.014
- Lee, S., Lee, S. M., Lee, S. H., et al. (2023). In situ photo-crosslinkable hyaluronic acid-based hydrogel embedded with GHK peptide nanofibers for bioactive wound healing. Acta Biomaterialia, 172, 159–174. https://doi.org/10.1016/j.actbio.2023.10.011
- Mao, S., Huang, J., Li, J., et al. (2025). Exploring the beneficial effects of GHK-Cu on an experimental model of colitis and the underlying mechanisms. Frontiers in Pharmacology, 16, 1551843. https://doi.org/10.3389/fphar.2025.1551843
- Bian, Y., Deng, M., Liu, J., et al. (2024). The glycyl-l-histidyl-l-lysine-Cu tripeptide complex attenuates lung inflammation and fibrosis in silicosis by targeting peroxiredoxin 6. Redox Biology, 75, 103237. https://doi.org/10.1016/j.redox.2024.103237
- Dymek, M., Olechowska, K., Hąc-Wydro, K., & Sikora, E. (2023). Liposomes as carriers of GHK-Cu tripeptide for cosmetic application. Pharmaceutics, 15(10), 2485. https://doi.org/10.3390/pharmaceutics15102485
- Ogórek, K., Nowak, K., Wadych, E., Ruzik, L., Timerbaev, A. R., & Matczuk, M. (2025). Are we ready to measure skin permeation of modern antiaging GHK-Cu tripeptide encapsulated in liposomes? Molecules, 30(1), 136. https://doi.org/10.3390/molecules30010136
- Mendias, C. L., & Awan, T. M. (2026). Safety and efficacy of approved and unapproved peptide therapies for musculoskeletal injuries and athletic performance. Sports Medicine. https://doi.org/10.1007/s40279-026-02437-0
- International Organization for Standardization. (2017). ISO/IEC 17025:2017 — General requirements for the competence of testing and calibration laboratories. https://www.iso.org/standard/66912.html
